×
About 231,530 results

ALLMedicine™ Heart Failure Center

Research & Reviews  104,741 results

Regional adiposity, cardiorespiratory fitness, and left ventricular strain: an analysis...
https://doi.org/10.1186/s12968-021-00757-w 10.1001/jama.1991.03470020057032 10.1056/NEJMoa020245 10.1016/j.mcna.2004.04.011 10.1161/CIRCULATIONAHA.115.016801 10.1161/CIRCHEARTFAILURE.118.005629 10.1016/j.jacc.2016.11.081 10.1016/j.ahj.2014.10.017 10.1016/j.numecd.2015.03.016 10.1161/CIRCIMAGING.113.000532 10.1016/j.jchf.2014.01.004 10.1016/j.jchf.2016.11.014 10.1016/j.jchf.2018.07.009 10.1056/NEJMoa032566 10.1016/j.jacc.2009.04.061 10.1093/eurheartj/eht133 10.1016/j.amjcard.2017.07.031 10.1016/j.amjcard.2004.02.058 10.1016/j.amjcard.2016.05.043 10.1249/MSS.0000000000000211 10.1161/CIRCULATIONAHA.105.574400 10.1088/0031-9155/45/6/318 10.1161/01.CIR.101.9.981 10.1016/j.amjcard.2014.08.037 10.1111/echo.14257 10.1177/2047487319891286 10.1016/j.jacc.2015.01.061 10.1038/ijo.2009.286 10.1161/CIRCULATIONAHA.117.029617 10.1038/hr.2011.157 10.1161/CIRCULATIONAHA.106.675355 10.1001/2012.jama.11132 10.1210/jc.2006-0814 10.1111/j.1532-5415.2005.00624.x 10.1002/ejhf.754 10.1136/bmjdrc-2015-000081 10.2337/diacare.26.8.2341 10.7326/M14-2525 10.1038/nri2921 10.1161/CIRCHEARTFAILURE.112.000054 10.1111/ejhf.37 10.1016/j.ahj.2016.12.006 10.1002/ejhf.1433 10.1161/CIRCULATIONAHA.119.044865 10.1016/j.pcad.2020.09.005 10.1111/cob.12278 10.1161/CIRCULATIONAHA.116.025629 10.1161/CIRCULATIONAHA.120.050941 10.1056/NEJMoa1212914 10.1001/jamacardio.2018.2454 10.1016/j.cpcardiol.2019.03.006
Journal of Cardiovascular Magnetic Resonance : Official J... Kondamudi N, Thangada N et. al.

Jun 14th, 2021 - Low cardiorespiratory fitness (CRF), high body mass index, and excess visceral adiposity are each associated with impairment in left ventricular (LV) peak circumferential strain (Ecc), an intermediate phenotype that precedes the development of cli...

Artificial Intelligence-Augmented Electrocardiogram Detection of Left Ventricular Systo...
https://doi.org/10.1016/j.mayocp.2021.02.029
Mayo Clinic Proceedings; Kashou AH, Medina-Inojosa JR et. al.

Jun 14th, 2021 - To validate an artificial intelligence-augmented electrocardiogram (AI-ECG) algorithm for the detection of preclinical left ventricular systolic dysfunction (LVSD) in a large community-based cohort. We identified a randomly selected community-base...

Patient-Reported Outcomes in Patients with Cardiomyopathy.
https://doi.org/10.1007/s11886-021-01511-5 10.1161/CIRCULATIONAHA.106.670901 10.1161/01.CIR.0000136991.85540.A9 10.1016/j.ahj.2004.12.010 10.1016/S2214-109X(17)30196-1 10.1161/CIR.0b013e3182949a2e 10.1001/jama.279.5.371 10.1016/S1053-2498(01)00298-4 10.1016/S0735-1097(00)00531-3 10.1016/j.jval.2018.05.008 10.1016/0735-1097(94)00397-9 10.1016/0002-9149(94)90555-X 10.1016/0002-9149(93)90582-W 10.1016/0002-8703(92)90986-6 10.1016/j.ahj.2008.09.020 10.1016/S0895-4356(02)00537-1 10.1023/A:1015547713061 10.1016/j.jchf.2016.04.010 10.1007/s11136-008-9416-4 10.1016/j.jacc.2005.11.021 10.1016/S0002-9149(96)00463-8 10.1161/CIRCHEARTFAILURE.113.000359 10.1016/j.cardfail.2007.04.001 10.1001/jamacardio.2017.3983 10.1161/CIRCHEARTFAILURE.112.970053 10.1016/j.jchf.2015.10.015 10.1191/026921501680425216 10.1186/s12955-020-01368-2 10.1161/CIRCOUTCOMES.115.001958 10.1007/s11136-016-1267-9 10.1001/jama.2009.457 10.1056/NEJMoa2022190 10.1016/S0140-6736(20)31792-X 10.1001/jama.2020.15922 10.1016/j.jacc.2019.02.010 10.1161/CIRCULATIONAHA.119.044138 10.1161/CIRCULATIONAHA.119.042929 10.1016/j.jacc.2019.09.007 10.1016/j.cardfail.2019.07.024 10.1056/NEJMoa1805689 10.1016/j.pec.2018.03.006 10.1016/j.jacc.2017.05.030 10.1001/jamacardio.2017.2039 10.1161/CIRCHEARTFAILURE.114.001937 10.1001/jamainternmed.2015.0315 10.1016/j.jchf.2014.06.011 10.1002/ejhf.151 10.1093/eurjhf/hfs074 10.1016/j.jacc.2012.06.054 10.1016/j.cardfail.2012.04.004 10.1161/CIRCULATIONAHA.111.040022 10.1093/eurheartj/ehr343 10.1056/NEJMoa0908355 10.1007/s10557-007-6034-2 10.1016/j.jacc.2020.09.542 10.1161/JAHA.119.013047 10.1161/CIRCOUTCOMES.120.007027 10.1200/JCO.2015.63.0830 10.3109/14017431.2015.1035319 10.1056/NEJMoa1409077 10.1056/NEJMoa1911303 10.1056/NEJMoa2022190 10.1056/NEJMoa0908355 10.1016/S0140-6736(10)61198-1 10.1016/j.jchf.2019.12.015 10.1016/j.jacc.2019.02.015 10.1016/j.jacc.2018.04.070
Current Cardiology Reports; Garcia RA, Benton MC et. al.

Jun 14th, 2021 - As medicine strives to become more patient-centered, patient-reported outcomes (PROs) are often used to describe patients' symptoms, function, and quality of life. This review describes the key concepts of PROs specific to heart failure in clinica...

SARS-CoV-2 and hypertension.
https://doi.org/10.14814/phy2.14800
Physiological Reports; Ravichandran B, Grimm D et. al.

Jun 14th, 2021 - The objective of this review is to give an overview of the pathophysiological effects of the Coronavirus Disease 2019 (COVID-19) in relation to hypertension (HT), with a focus on the Renin-Angiotensin-Aldosterone System (RAAS) and the MAS receptor...

Psychosocial factors, mental health, and coordination capacity in patients with heart f...
https://doi.org/10.1002/ehf2.13468
ESC Heart Failure; Bekfani T, Nisser J et. al.

Jun 14th, 2021 - Patients with heart failure (HF) suffer from reduced quality-of-life (QoL). We aimed to compare QoL, depression, and anxiety scores among outpatients with preserved (HFpEF) and reduced (HFrEF) ejection fraction and non-HF controls and its relation...

see more →

Guidelines  339 results

PIROUETTE: Pirfenidone Reduced Myocardial Fibrosis in HFpEF Patients
https://www.acc.org/latest-in-cardiology/articles/2021/05/12/19/40/mon-8am-pirouette-acc-2021
ACC News Story

May 16th, 2021 - Pirfenidone reduced myocardial fibrosis in patients with heart failure with preserved ejection fraction (HFpEF), according to data from the early-phase PIROUETTE trial presented May 17 during ACC.21. While further investigation is needed, it sugge...

Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation R...
https://doi.org/10.1001/jama.2021.4987
JAMA , Krist AH et. al.

Apr 27th, 2021 - Hypertension is a prevalent condition that affects approximately 45% of the adult US population and is the most commonly diagnosed condition at outpatient office visits. Hypertension is a major contributing risk factor for heart failure, myocardia...

CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care...
https://doi.org/10.1016/j.cjca.2021.01.017
The Canadian Journal of Cardiology; McDonald M, Virani S et. al.

Apr 8th, 2021 - In this update of the Canadian Cardiovascular Society heart failure (HF) guidelines, we provide comprehensive recommendations and practical tips for the pharmacologic management of patients with HF with reduced ejection fraction (HFrEF). Since the...

Most COVID-19 hospitalizations due to four conditions
https://www.nih.gov/news-events/nih-research-matters/most-covid-19-hospitalizations-due-four-conditions
NIH Research Matters; National Institutes of Health (NIH)

Mar 8th, 2021 - Studies show that certain common medical conditions put people at higher risk for severe illness from COVID-19. These include metabolic disorders like type 2 diabetes and obesity, as well as heart conditions like high blood pressure (hypertension)...

Coffee lovers, rejoice! Drinking more coffee associated with decreased heart failure risk
https://newsroom.heart.org/news/coffee-lovers-rejoice-drinking-more-coffee-associated-with-decreased-heart-failure-risk
American Heart Association

Feb 8th, 2021 - DALLAS, Feb. 9, 2021 — Dietary information from three large, well-known heart disease studies suggests drinking one or more cups of caffeinated coffee may reduce heart failure risk, according to research published today in Circulation: Heart Failu...

see more →

Drugs  2,891 results see all →

Clinicaltrials.gov  114,389 results

Frailty and the Risk of Incident Heart Failure in Older Men
https://www.medscape.com/viewarticle/953261

Jun 16th, 2021 - Takeaway Frailty, as measured by the combination of slow gait speed, low chair-stand time and difficulty with balance, was associated with an increased risk of developing heart failure (HF). Frailty as defined by the Fried index demonstrated a wea...

Digoxin - digoxin tablet-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ae4022d-ec54-4457-9d67-59a493a17476

Jun 15th, 2021 - Digoxin Tablets are a cardiac glycoside indicated for: Treatment of mild to moderate heart failure in adults. ( 1.1) Increasing myocardial contractility in pediatric patients with heart failure. ( 1.2) Control of resting ventricular rate in patien...

Spironolactone - spironolactone tablet, film coated-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=26a3a364-9296-4d68-8871-af01809b96bd

Jun 15th, 2021 - Spironolactone is an aldosterone antagonist indicated for: The treatment of NYHA Class III–IV heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need for hospitalization for heart failure ( 1.1) Use a...

Spironolactone - spironolactone tablet, film coated-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1327c962-3302-4da2-b4c3-700e7c4d9d9c

Jun 15th, 2021 - Spironolactone is an aldosterone antagonist indicated for: The treatment of NYHA Class III–IV heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need for hospitalization for heart failure ( 1.1) Use a...

Chlorthalidone - chlorthalidone tablet-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4a657a5a-584c-4119-a6ba-68a40bb4e335

Jun 15th, 2021 - Diuretics such as chlorthalidone are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension. Chlorthalidone is indicated as...

see more →

News  9,035 results

Frailty and the Risk of Incident Heart Failure in Older Men
https://www.medscape.com/viewarticle/953261

Jun 16th, 2021 - Takeaway Frailty, as measured by the combination of slow gait speed, low chair-stand time and difficulty with balance, was associated with an increased risk of developing heart failure (HF). Frailty as defined by the Fried index demonstrated a wea...

Bariatric Surgery Tied to Fewer HFpEF Hospitalizations
https://www.medscape.com/viewarticle/953123

Jun 14th, 2021 - Patients who underwent metabolic and bariatric surgery had fewer than half the number of hospitalizations for both acute and chronic episodes of heart failure with preserved ejection fraction (HFpEF) in a retrospective analysis of more than 2 mill...

Possible 'Treatment' May Cut HFpEF Risk from Subclinical Myocardial Injury in Blacks
https://www.medscape.com/viewarticle/953062

Jun 13th, 2021 - African Americans with biomarker evidence of heart damage may cut their risk for at least some forms of heart failure (HF) with greater participation in at least moderate-intensity exercise, suggests a new analysis from a venerable cohort study. I...

Skill Checkup: An Electrical Conundrum
https://reference.medscape.com/viewarticle/952644

Jun 10th, 2021 - The Skill Checkup series provides a quick, case-style interactive quiz highlighting key guidelines- and evidence-based information to inform clinical practice. A 76-year-old man presented with syncope preceded by prolonged dizziness. His medical h...

Fast Five Quiz: Heart Failure With Reduced Ejection Fraction (HFrEF)
https://reference.medscape.com/viewarticle/931020

Jun 9th, 2021 - According to a consensus statement from the Heart Failure Society of America (HFSA), Heart Failure Association of the European Society of Cardiology (HFA), and Japanese Heart Failure Society (JHFS), the syndrome known as heart failure (HF) is char...

see more →

Patient Education  135 results see all →